🌟 Join Our Team 🌟 We’re growing at #uBriGene_Biosciences, and we’re looking for a detail-oriented #Accountant_Associate to help drive our financial success. If you have a knack for numbers, experience in finance (especially in biotech or pharma), and speak both Mandarin and English, we’d love to chat with you! If you're passionate about making an impact and want to grow with us, apply now! We can't wait to meet you. 😊
uBriGene Biosciences Inc.
Biotechnology
Richmond, British Columbia 1,761 followers
Your bridge from ATMPs concept to commercialization
About us
uBriGene Biosciences is your bridge from ATMPs concept to commercialization. Our CDMO+ services include cell therapy products (CAR-T, TCR-T, NK Cells, iPSC, Dendritic cells, Macrophages), viral vectors (AAV, LVV, RVV, AdV, oncolytic viruses), plasmids, and RNA (mRNA, circRNA, acRNA). Our extensive experience in manufacturing, QC testing, and regulatory filing support of ATMPs, from early discovery to commercialization, will accelerate your therapeutic programs from bench to bedside. With four Centers of Excellence in North America, and Asia Pacific and more than 20 GMP clean room suites, uBriGene supports global CGT, vaccine, and RNA product development.
- Website
-
www.ubrigene.com
External link for uBriGene Biosciences Inc.
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Richmond, British Columbia
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Gene and Cell, Car-T, Clinical applications, CRO, CDMO, Plasmids, Viral Vector, Gene editing, mRNA, and Advanced therapy medicinal products
Locations
-
Primary
13351 Commerce Pkwy
1208
Richmond, British Columbia V6V 2X7, CA
Employees at uBriGene Biosciences Inc.
-
Kenneth Warrington
Executive Director, Strategic Business Development & Head- Technical Services
-
Alex Chen
Cell & Gene Therapy CDMO
-
Baker Lu
Cell and Gene Therapy Project Management, Gene and Cell therapy CRO/CDMO products, T cell, iPSC, plasmid DNA, lenti-virus, AAV, Ad, enzymes, reagents
-
Scott Pattison
Builder of Impactful Biotech Strategic Partnerships
Updates
-
#uBriGene at the 16th Oncolytic Virotherapy Conference in Rotterdam! We're beyond excited to share our groundbreaking research on "Amplification of Lister Strain Vaccinia Virus in Human Embryonic Kidney 293XS Cells Cultured in Suspension." Our team has developed an innovative way to produce #vaccinia_virus using HEK 293XS cells in suspension, paving the way for more effective #viral_vectors in #vaccines and cancer therapies. 🧬 But it's not just about the science—we’d love to connect with you at the 16th Annual International #Oncolytic_Virotherapy Conference, happening from October 27-30, 2024, in the vibrant city of #Rotterdam! Stop by to meet our team in person, dive into our research, and let’s talk about how uBriGene's advanced services can help take your R&D projects to new heights. 👉 Looking to accelerate your R&D? Let’s connect at the event!
-
-
🌟 Job Openings at uBriGene Biosciences Inc. Join our innovative team at #uBriGene, where we’re advancing the future of cell and gene therapy! We are looking for passionate professionals to fill multiple key roles: 1/ MSAT Scientist – Cell Therapy Tech Transfer 2/ QA Director If you're ready to make a real impact in biotech, apply today and help shape tomorrow's treatments! Apply now via https://lnkd.in/gpHMKyE3
-
-
🌟 We are hiring! #uBriGene_Biosciences is seeking a motivated QC Analyst - Cell & Gene Therapy Product Release to join our team, where you will play a crucial role in the release testing of #cell_and_gene_therapy products within a #GMP environment. If you are passionate about innovative #biotechnology and excel in a fast-paced setting, this could be the ideal opportunity for you. 🧬Check here for more open positions https://lnkd.in/gpHMKyE3
-
-
🚀 Join uBriGene at the Cell & Gene Meeting on the Mesa 2024! 🌟 We’re excited to participate in the premier conference for the #cell_and_gene_therapy sector from October 7 to 9 in Phoenix, AZ! Connect with industry leaders as we tackle commercialization challenges and advance transformative research. #uBriGene is your bridge from ATMP concept to commercialization! Our CDMO+ services include cutting-edge cell therapies, viral vectors, plasmids, and RNA solutions. With four Centers of Excellence and over 20 GMP clean rooms, we accelerate therapeutic programs from bench to bedside. Let’s connect! Our team will be available for meetings through the partnering platform. Don’t miss this chance to explore how we can overcome today’s challenges together. See you at the Cell & Gene #Meeting_on_the_Mesa_2024! 🌍✨
-
-
🧬 Get Ready for "RNA Manufacturing 101"! 🧬 Join us tomorrow, September 26, at 12:00 PM EST for an exciting episode in #uBriGene’s Educational Live Webinar series! Dive into the cutting-edge world of RNA therapies—post-COVID innovations are reshaping vaccine development and treatments. Don’t miss out on this opportunity to enhance your knowledge! 🔗 Register now for FREE via https://lnkd.in/g-3at8mQ See you there! 🚀
🧬 September 2024 Webinar on "RNA Manufacturing 101" 🧬 Excited for the next episode in #uBriGene’s Educational Live Webinar series? Join us for "RNA Manufacturing 101 - IVT Workflows for GMP Manufacturing" 🗓️ Date: September 26th, Thursday 🕛 Time: 12:00 PM EST 🎤 Presenter: Kenneth Warrington, Ph.D., Head of Technical Services Since Covid-19, #RNA_based_therapies, are advancing rapidly, impacting not just vaccine development but also expanding into treatments for various diseases. This webinar will cover the latest in RNA drug development and the pivotal role of in vitro transcription (IVT) in GMP manufacturing workflows. What You’ll Learn: - Basics of RNA drug development and the current landscape, including siRNA, sgRNA, #mRNA, circRNA, saRNA and more. - Overview of #GMP_manufacturing workflows for RNA therapies. - Key aspects of in-process and release testing panels. This session is ideal for professionals aiming to enhance their understanding of RNA manufacturing processes and ensure their workflows meet GMP standards. 🔗 Register now for free and secure your spot via https://lnkd.in/g-3at8mQ Don’t miss out—secure your place today and stay ahead in the fast-evolving world of RNA-based therapeutics! 🚀
-
-
Excited to host our private lunch session on “How Technology Innovations Can Make CGT More Affordable”! It was a great opportunity to engage with industry leaders and discuss the critical role of technology in reducing costs and increasing access to #cell_and_gene_therapies. Thanks to everyone for the engaging discussions! Let’s make transformative therapies accessible to all!🚀 #9th_CAR_TCR_Summit #uBriGene_Biosciences
-
-
🧬 September 2024 Webinar on "RNA Manufacturing 101" 🧬 Excited for the next episode in #uBriGene’s Educational Live Webinar series? Join us for "RNA Manufacturing 101 - IVT Workflows for GMP Manufacturing" 🗓️ Date: September 26th, Thursday 🕛 Time: 12:00 PM EST 🎤 Presenter: Kenneth Warrington, Ph.D., Head of Technical Services Since Covid-19, #RNA_based_therapies, are advancing rapidly, impacting not just vaccine development but also expanding into treatments for various diseases. This webinar will cover the latest in RNA drug development and the pivotal role of in vitro transcription (IVT) in GMP manufacturing workflows. What You’ll Learn: - Basics of RNA drug development and the current landscape, including siRNA, sgRNA, #mRNA, circRNA, saRNA and more. - Overview of #GMP_manufacturing workflows for RNA therapies. - Key aspects of in-process and release testing panels. This session is ideal for professionals aiming to enhance their understanding of RNA manufacturing processes and ensure their workflows meet GMP standards. 🔗 Register now for free and secure your spot via https://lnkd.in/g-3at8mQ Don’t miss out—secure your place today and stay ahead in the fast-evolving world of RNA-based therapeutics! 🚀
-
-
Join Us at the 9th CAR-TCR Summit: Exclusive Lunch & Learn with #uBriGene_Biosciences! We’re thrilled to be part of the #9th_CAR_TCR_Summit in Boston on September 18-19, 2024! Come visit us at booth #13 to chat about our latest breakthroughs in cell and gene therapy. Special Invite: On September 19 from 1:00 pm to 2:00 pm, join us for a lunch & learn in room #204. Enjoy a great meal while Dr. Xiulian Sun shares insights on "How Technology Innovations Can Make #Cell_and_Gene_Therapy More Affordable." We’d love to see you at the 9th CAR-TCR Summit at #Hynes_Convention_Center. Space is limited, so be sure to RSVP by August 16 to secure your spot. 🔗 Register now via https://lnkd.in/gswkpD3Q. Looking forward to connecting and exploring how we can advance cell therapy together! 🚀 For conference registration and further details about the CAR-TCR Summit, please contact the event organizer, #hansonwade, directly.
-
-
🚀 uBriGene Advanced GMP sgRNA IVT Platform! 🚀 Our cutting-edge platform, leveraging in vitro transcription for cost-effective, high purity sgRNA production without organic solvents, is designed to revolutionize the production of #sgRNA. Here’s why #GMP_sgRNA_IVT_platform provided by #uBriGene stands out: 🔹 Cost-Effective: Lower production costs with no organic chemicals. 🔹 Enhanced Efficiency: Patented aptamer sequence boosts stability and gene editing. 🔹 Flexible Partnership: Tailored processes and proactive support. 🔹 Optimized Manufacturing: Scalable, high-purity production (>90%). 🔹 Top-Notch Quality: Robust QMS and full compliance with FDA/EMA/NMPA standards. Elevate your #gene_editing projects with precision and efficiency. Connect with us to learn more via https://lnkd.in/g2wk_ncm
-